Rigosertib
Cat.No:IR2440 Solarbio
CAS:592542-59-1
Molecular Formula:C21H25NO8S
Molecular Weight:451.49
Storage:Powder:-20℃,2 years
Purity:≥98%
Appearance:Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Cell Cycle >
RigosertibCAS:592542-59-1
Molecular Formula:C21H25NO8S
Molecular Weight:451.49
Storage:Powder:-20℃,2 years
Purity:≥98%
Appearance:Solid
Qty:
Size:
CAS | 592542-59-1 |
Name | Rigosertib |
Molecular Formula | C21H25NO8S |
Molecular Weight | 451.49 |
Solubility | Soluble in DMSO ≥5mg/mL(This product is not stable in solution, it is recommended that you use it now) |
Purity | ≥98% |
Appearance | Solid |
Storage | Powder:-20℃,2 years |
SMILES | COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)NCC(=O)O |
InChIKey | OWBFCJROIKNMGD-BQYQJAHWSA-N |
InChI | InChI=1S/C21H25NO8S/c1-27-15-10-19(29-3)16(20(11-15)30-4)7-8-31(25,26)13-14-5-6-18(28-2)17(9-14)22-12-21(23)24/h5-11,22H,12-13H2,1-4H3,(H,23,24)/b8-7+ |
PubChem CID | 6918736 |
Target Point | Polo-like Kinase (PLK) |
Passage | Cell Cycle |
Background | Rigosertib is a multi-kinase inhibitor and selective anticancer compound that induces cell apoptosis by inhibiting PI3K/Akt pathway, promoting phosphorylation of histone H2AX and inducing G2/M phase arrest in the cell cycle. Rigosertib is a selective non-ATP-competitive PLK1 inhibitor. |
Unit | Bottle |
Specification | 1mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.